United States:
FDA Amends Regulations To Reflect Name Change Of Anti-Infective Drugs Advisory Committee Name
To print this article, all you need is to be registered or login on Mondaq.com.
In the April 6, 2015, Federal Register, FDA
announced an amendment to the standing advisory committees'
regulations changing the name of the Anti-Infective Drugs Advisory
Committee. The committee name has been changed to the Antimicrobial
Drugs Advisory Committee to better reflect the products and issues
brought to the committee.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
